SBRA — Sabra Health Care REIT, Inc. stock price, charts and financials

NASDAQ·Real Estate·REIT - Healthcare Facilities·USA

Latest market price

20.61

-0.56-2.65%

Overview Short InterestFilings

SBRAQT49Sabra Health Care REIT, Inc.·NASDAQ

Overview Short InterestFilings

20.61-2.65%

Earnings

Down 2.6% — Reported earnings — EPS in line, revenue beat by 6%.

High confidence

Loading chart...

Screen all →

HR-2.24%$20.54 NHI-0.93%$75.94 MPW+0.00%$5.50 CTRE-1.72%$41.22 MPT-0.86%$4.59 AHR-0.86%$55.12 DHC-1.01%$8.81 LTC-3.31%$38.91

Snapshot

Index	-	P/E	32.87	EPS (ttm)	0.64	Insider Own	1.85%	Shs Outstand	252.19M	Perf Week	-5.32%

Market Cap	5.34B	Forward P/E	27.11	EPS next Y	0.78	Insider Trans	-0.33%	Shs Float	247.92M	Perf Month	7.57%

Enterprise Value	7.91B	PEG	4.93	EPS next Q	-	Inst Own	-	Short Float	10.08%	Perf Quarter	2.47%

Income	156.43M	P/S	6.57	EPS this Y	9.40%	Inst Trans	-	Short Ratio	8.81	Perf Half Y	14.31%

Sales	812.84M	P/B	1.92	EPS next Y	13.31%	ROA	2.79%	Short Interest	24.99M	Perf YTD	11.77%

Book/sh	-	P/C	14.56	EPS next 5Y	-	ROE	5.61%	52W High	22.17 -7.03%	Perf Year	17.87%

Cash/sh	-	P/FCF	14.56	EPS past 3/5Y	- -0.91%	ROIC	4.16%	52W Low	16.72 23.30%	Perf 3Y	61.23%

Dividend Est.	1.20 (5.82%)	EV/EBITDA	16.95	Sales past 3/5Y	7.43% 5.29%	Gross Margin	63.48%	Volatility	2.30% 2.66%	Perf 5Y	15.18%

Dividend TTM	1.20 (5.82%)	EV/Sales	9.73	EPS Y/Y TTM	16.67%	Oper. Margin	28.98%	ATR (14)	0.57	Perf 10Y	-10.98%

Dividend Ex-Date	May 15, 2026	Quick Ratio	13.85	Sales Y/Y TTM	15.65%	Profit Margin	19.21%	RSI (14)	55.56	Recom	2.69

Dividend Gr. 3/5Y	0.00% -2.33%	Current Ratio	13.85	EPS Q/Q	-56.76%	SMA20	1.73%	Beta	0.61	Target Price	22.50

Payout	188.10%	Debt/Eq	0.97	Sales Q/Q	20.65%	SMA50	6.69%	Rel Volume	0.78	Prev Close	21.17

Employees	58	LT Debt/Eq	0.83	Earnings	Aug 03	SMA200	8.23%	Avg Volume	3.01M	Price	20.61

IPO Date	Apr 02, 2002	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.87% 6.00%	Net Debt/EBITDA	5.51	Volume	2,342,409	Change	-2.65%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Jul-22-26	Reiterated	UBS	Neutral	$22 → $25
Jul-22-26	Reiterated	Robert W. Baird		$22 → $23
Jul-08-26	Upgrade	Truist Securities	Hold → Buy	$21 → $22
Jul-07-26	Reiterated	Barclays	Equal Weight	$21
Jun-23-26	Downgrade	Citigroup	Buy → Neutral
Jun-18-26	Reiterated	UBS	Neutral	$22 → $19
May-21-26	Reiterated	Scotiabank	Sector Perform	$15 → $22
May-13-26	Reiterated	UBS	Neutral	$21 → $22
May-11-26	Reiterated	Cantor Fitzgerald	Neutral	$21 → $22
Feb-19-26	Reiterated	UBS	Neutral	$21

Latest News

Today

Today06:46PM

Sabra Healthcare (SBRA) Tops Q2 FFO and Revenue Estimateszacks.com

Jul-31-26

Jul-31-2604:13AM

First Trust Advisors LP Raises Holdings in Sabra Healthcare REIT, Inc. $SBRAdefenseworld.net

Jul-27-26

Jul-27-2604:04AM

Entropy Technologies LP Purchases 93,021 Shares of Sabra Healthcare REIT, Inc. $SBRAdefenseworld.net

Jul-26-26

Jul-26-2609:00AM

The Fed's Crude DilemmaSeekingAlpha

Jul-23-26

Jul-23-2610:00AM

Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Reportgurufocus.com

Jul-22-26

Jul-22-2609:36AM

Strength Seen in Sabra (SBRA): Can Its 10.2% Jump Turn into More Strength?zacks.com

Jul-21-26

Jul-21-2605:33PM

Why Sabra Health Care REIT Stock Soared Todayfool.com

09:05AM

Sabra Issues Business Update and Increases Full-Year 2026 Guidancebusinesswire.com

Jul-20-26

Jul-20-2608:05PM

Sabra Health Care REIT, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference CallYahoo

Jul-12-26

Jul-12-2610:04PM

Better Senior Housing REIT: Sabra Health Care or Welltower?fool.com

Jul-09-26

Jul-09-2605:44PM

Sabra Health Care: Pivoting To Win From An Unstoppable Demographic Tailwindseekingalpha.com

Jul-07-26

Jul-07-2605:53AM

Barclays Initiates Coverage On Sabra Health Care REIT with Equal-Weight Rating, Announces Price Target of $21Benzinga

Jun-24-26

Jun-24-2610:01AM

National Health Investors: The Silver Tsunami Makes This REIT UndervaluedSeekingAlpha

Jun-23-26

Jun-23-2611:59AM

Here Are Tuesday’s Best Wall Street Analyst Research Calls: Centene, Darden Restaurants, Flutter Entertainment, GE Healthcare, IBM, Nike, SpaceX, Synopsys, Target, and MoreYahoo

10:36AM

Citigroup Downgrades Sabra Health Care REIT to Neutral, Lowers Price Target to $19Benzinga

Company

Sabra Health Care REIT, Inc. engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	813	775	703	648	625	570	599	668	623
Cost of Goods Sold Incl. D&A	297	271	227	195	163	141	132	110	50
Gross Profit	515	504	476	452	462	428	467	558	574
Selling, General and Administrative Excl. Other	57	54	50	47	40	35	33	31	36
Research and Development	0	0	0	0	0	0	0	0	0
Other Operating Expense	224	186	169	184	187	183	434	0	231
Operating Income	236	264	257	222	235	211	0	528	307
Interest Expense	116	112	115	113	105	99	100	127	147
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	36	6	-14	-93	-206	-224	240	-329	122
Net Income Before Taxes	156	157	128	16	-76	-111	139	72	282
Income Taxes	1	2	1	2	1	2	1	3	3
Consolidated Net Income	157	156	127	14	-78	-113	138	69	279
Net Income From Continuing Operations	155	156	127	14	-78	-113	138	69	279
Net Income	157	156	127	14	-78	-113	138	69	279
EPS (Recurring)	0.64	0.64	0.54	0.06	-0.34	-0.52	0.67	0.37	1.57
EPS (Basic, Before Extraordinaries)	0.64	0.64	0.54	0.06	-0.34	-0.52	0.67	0.37	1.57
EPS (Diluted)	0.63	0.64	0.54	0.06	-0.34	-0.52	0.67	0.37	1.56
EBITDA	466	457	413	312	217	166	416	527	512
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	32.71	29.59	32.07	241.46	—	—	25.93	57.68	10.56
Price To Sales Ratio	6.39	5.89	5.74	5.09	4.59	5.20	5.97	5.97	4.71
Gross Margin	63.35	65.03	67.71	69.75	73.92	75.09	77.96	83.53	92.13
Operating Margin	29.03	34.06	36.56	34.26	37.60	37.02	0.00	79.04	49.28
Net Margin	19.31	20.13	18.07	2.16	-12.48	-19.82	23.04	10.33	44.78
Shares Outstanding	252	241	233	231	231	219	206	187	178
Market Capitalization	5,194	4,565	4,036	3,296	2,871	2,965	3,578	3,991	2,933
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FLORES JESSICA	Executive VP & CAO	Mar 25 '26	Sale	19.86	15,231	302,488	71,709	Mar 26
FOSTER MICHAEL J	Director	May 20 '25	Sale	18.22	11,000	200,376	64,725	May 22
Cusack Catherine	Director	Feb 24 '25	Buy	15.92	1,500	23,880	60,583	Feb 25
Cusack Catherine	Director	Feb 21 '25	Buy	16.43	1,000	16,435	59,083	Feb 25
Cusack Catherine	Director	May 22 '24	Buy	14.43	7,000	101,010	46,385	May 23
FOSTER MICHAEL J	Director	May 14 '24	Sale	14.68	10,000	146,830	63,923	May 17
Costa Michael Lourenco	Executive VP, CFO & Secretary	Sep 01 '23	Buy	12.63	1,947	24,591	183,218	Sep 05
Cusack Catherine	Director	Feb 25 '22	Buy	13.24	2,000	26,480	14,994	Mar 02

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.